These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 31014563)
1. Corrigendum to "Synthesis and SAR of novel capsazepine analogs with significant anti-cancer effects in multiple cancer types" [Bioorg. Med. Chem. 27 (1) (2019) 208-215]. De La Chapa J; Valdez M; Ruiz F; Gonzales K; Mitchell W; McHardy SF; Hart MJ; Polusani SR; Gonzales CB Bioorg Med Chem; 2019 Jun; 27(11):2280. PubMed ID: 31014563 [No Abstract] [Full Text] [Related]
2. Corrigendum to "Metal-assisted synthesis of unsymmetrical magnolol and honokiol analogs and their biological assessment as GABA Rycek L; Puthenkalam R; Schnürch M; Ernst M; Mihovilovic MD Bioorg Med Chem Lett; 2015 Apr; 25(8):1811. PubMed ID: 28718421 [No Abstract] [Full Text] [Related]
3. Corrigendum to "Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents" [Bioorg. Med. Chem. 19 (2011) 5409-5419]. Kumar A; Tripathi VD; Kumar P; Gupta LP; Akanksha ; Trivedi R; Bid H; Nayak VL; Siddiqui JA; Chakravarti B; Saxena R; Dwivedi A; Siddiquee MI; Siddiqui U; Konwar R; Chattopadhyay N Bioorg Med Chem; 2019 Sep; 27(17):3960-3961. PubMed ID: 31345744 [No Abstract] [Full Text] [Related]
4. Commentary to "The structure of McN-5652" [Bioorg. Med. Chem. 9 (2001) 2105] and to the corrigendum to "The structure of McN-5652" [Bioorg. Med. Chem. 10 (2002) 3368]. Maryanoff BE Bioorg Med Chem; 2002 Oct; 10(10):3367. PubMed ID: 12150884 [No Abstract] [Full Text] [Related]
5. Corrigendum to "Challenges in the development of an M Tarr JC; Wood MR; Noetzel MJ; Melancon BJ; Lamsal A; Luscombe VB; Rodriguez AL; Byers FW; Chang S; Cho HP; Engers DW; Jones CK; Niswender CM; Wood MW; Brandon NJ; Duggan ME; Jeffrey Conn P; Bridges TM; Lindsley CW Bioorg Med Chem Lett; 2018 Sep; 28(17):3014. PubMed ID: 30076050 [No Abstract] [Full Text] [Related]
6. Corrigendum to 'Novel carbocyclic nucleoside analogs suppress glomerular mesangial cells proliferation and matrix protein accumulation through ROS-dependent mechanism in the diabetic milieu. II. Acylhydrazone-functionalized pyrimidines' [Bioorg. Med. Chem. Lett. 26 (2016) 1020-1024]. Bouhadir KH; Koubeissi A; Mohsen FA; Diab El-Harakeh M; Cheaib R; Younes J; Azzi G; Eid AA Bioorg Med Chem Lett; 2019 Aug; 29(16):2439. PubMed ID: 31262558 [No Abstract] [Full Text] [Related]
7. Corrigendum to "Novel salicylanilides from 4,5-dihalogenated salicylic acids: Synthesis, antimicrobial activity and cytotoxicity" [Bioorg. Med. Chem. 25 (2017) 1524-1532]. Paraskevopoulos G; Monteiro S; Vosátka R; Krátký M; Navrátilová L; Trejtnar F; Stolaříková J; Vinšová J Bioorg Med Chem; 2017 Apr; 25(8):2530. PubMed ID: 28285926 [No Abstract] [Full Text] [Related]
8. Corrigendum to "Synthesis and biological evaluations of new nitric oxide-anti-inflammatory drug hybrids" [Bioorg Med Chem Lett (2017) 4358-4369]. Abdelall EKA; Abdelhamid AO; Azouz AA Bioorg Med Chem Lett; 2018 Feb; 28(4):839. PubMed ID: 29395977 [No Abstract] [Full Text] [Related]
10. Corrigendum to "Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides" [Bioorg. Med. Chem. Lett. 26 (2016) 5867-5870]. Arslan T; Türkoğlu EA; Şentürk M; Supuran CT Bioorg Med Chem Lett; 2017 Aug; 27(16):3944. PubMed ID: 28705642 [No Abstract] [Full Text] [Related]
11. Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431]. Wu TM; Wang DC; Xiang P; Zhang JN; Sang YX; Lin HJ; Chen J; Xie G; Song H; Zhao YL; Xie YM Bioorg Med Chem Lett; 2016 Sep; 26(18):4558. PubMed ID: 27542309 [No Abstract] [Full Text] [Related]
12. Retraction notice to 'Corrigendum to "3-Benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis"' [Bioorg. Med. Chem. 20 (2012) 5668-5668]. Bioorg Med Chem; 2014 Dec; 22(23):6726. PubMed ID: 25756091 [No Abstract] [Full Text] [Related]
13. Corrigendum to "Design, synthesis, biological evaluation, and molecular docking of chalcone derivatives as anti-inflammatory agents" [Bioorg. Med. Chem. Lett. 27 (3) (2017) 602-606]. Li J; Li D; Xu Y; Guo Z; Liu X; Yang H; Wu L; Wang L Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3822. PubMed ID: 30385163 [No Abstract] [Full Text] [Related]
14. Corrigendum to "Synthesis of novel anticancer ruthenium-arene pyridinylmethylene scaffolds via three-component reaction" [Bioorg. Med. Chem. Lett. 26 (2016) 2695-2700]. Jadhav GR; Sinha S; Chhabra M; Paira P Bioorg Med Chem Lett; 2016 Aug; 26(16):4154-4155. PubMed ID: 27396504 [No Abstract] [Full Text] [Related]
15. Corrigendum to "Design and synthesis of novel thiadiazole-thiazolone hybrids as potential inhibitors of the human mitotic kinesin Eg5 [Bioorg Med Chem Lett 28 (17) (2018) 2930-2938]". Khathi SP; Chandrasekaran B; Karunanidhi S; Tham CL; Kozielski F; Sayyad N; Karpoormath R Bioorg Med Chem Lett; 2018 Nov; 28(21):3489. PubMed ID: 30279037 [No Abstract] [Full Text] [Related]
16. Corrigendum to "A cascade synthesis, in vitro cholinesterases inhibitory activity and docking studies of novel Tacrine-pyranopyrazole derivatives" [Bioorg. Med. Chem. Lett. 28 (14) (2018) 2481-2484]. Derabli C; Boualia I; Abdelwahab AB; Boulcina R; Bensouici C; Kirsch G; Debache A Bioorg Med Chem Lett; 2018 Oct; 28(18):3129. PubMed ID: 30119958 [No Abstract] [Full Text] [Related]
17. Corrigendum to "Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3" [Bioorg. Med. Chem. 23 (2015) 4871-4883]. Nakajima Y; Inoue T; Nakai K; Mukoyoshi K; Hamaguchi H; Hatanaka K; Sasaki H; Tanaka A; Takahashi F; Kunikawa S; Usuda H; Moritomo A; Higashi Y; Inami M; Shirakami S Bioorg Med Chem; 2017 May; 25(10):2813. PubMed ID: 28366269 [No Abstract] [Full Text] [Related]
18. Corrigendum to "Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3" [Bioorg. Med. Chem. 23 (2015) 4871-4883]. Nakajima Y; Inoue T; Nakai K; Mukoyoshi K; Hamaguchi H; Hatanaka K; Sasaki H; Tanaka A; Takahashi F; Kunikawa S; Usuda H; Moritomo A; Higashi Y; Inami M; Shirakami S Bioorg Med Chem; 2016 Sep; 24(18):4517. PubMed ID: 27544046 [No Abstract] [Full Text] [Related]
19. Corrigendum to "Rotenoisin A is a novel anti-adipogenic compound" [Bioorg. Med. Chem. Lett. 29 (2018) 89-96]. Cho HH; Park HS; Jang SH; Won C; Kim HD; Kim TH; Cho JH Bioorg Med Chem Lett; 2020 Aug; 30(16):127295. PubMed ID: 32571641 [No Abstract] [Full Text] [Related]
20. Corrigendum to "Synthesis and preliminary pharmacological evaluation of N-2-(4-(4-(2-substitutedthiazol-4-yl) piperazin-1-yl)-2-oxoethyl)acetamides as novel atypical antipsychotic agents" [Bioorg. Med. Chem. Lett. 18 (2008) 6054-6057]. Sekhar KVGC; Rao VS; Devambatla RKV; Kumar MMK Bioorg Med Chem Lett; 2017 May; 27(9):2081. PubMed ID: 28336140 [No Abstract] [Full Text] [Related] [Next] [New Search]